您好,欢迎来到科研在线!科研采购 · 选型 · 实验方法
首页产品库品牌馆产品类别品牌新闻会议会展产品试用求职招聘资讯专题教程
CEL / Cell Culture

DMEM/F12基础培养基

DMEM/F12培养基在DMEM培养基的基础上,添加F12培养基中更为丰富的营养成分 。广泛应用于多种哺乳类细胞的培养。 DMEM/F12培养基也常作为 无血清培养基的基础,也适用于低血清含量下哺乳动物细胞的培养以及克隆密度培养。

生物试剂 供应商 艾碧维 ↗ 型号 AW-M006 更新 2026-10-31
参考价格区间
¥70
含税参考价,实际以配置与渠道报价为准
本条目供应商 艾碧维原厂 498个条目 进入企业主页

01产品图片

02产品简介

DMEM/F12培养基在DMEM培养基的基础上,添加F12培养基中更为丰富的营养成分 。广泛应用于多种哺乳类细胞的培养。 DMEM/F12培养基也常作为 无血清培养基的基础,也适用于低血清含量下哺乳动物细胞的培养以及克隆密度培养。

03产品介绍

DMEM/F12培养基在DMEM培养基的基础上,添加F12培养基中更为丰富的营养成分。广泛应用于多种哺乳类细胞的培养。 DMEM/F12培养基也常作为 无血清培养基的基础,也适用于低血清含量下哺乳动物细胞的培养以及克隆密度培养。

DMEM/F12基础培养基由abiowell技术团队精心筛选验证,经过长期测试,本产品可保持多种细胞最佳的生长状态。

形态液体 细菌检测阴性谷氨酰胺2.5mMD-葡萄糖3151mg/LHEPES缓冲剂15mM 丙酮酸钠0.5mM碳酸氢钠含有酚红含有存储条件2℃-8℃,避光储存运输条件常温或者蓝冰有效期12个月供应限制仅供科研使用

认真做好每一个抗体, 每一个抗体都经过反复验证!

Traditional Chinese medicine is gaining prominence in lumbar disc herniation (LDH) management, but the mechanisms of its active compounds and their molecular targets remain largely unclear. Herein, we aim to elucidate the therapeutic mechanism of Gentisic acid by investigating its role in regulating S100A9 in LDH. Clinical analysis reveals that S100A9 expression and inflammatory levels correlat positively with LDH severity. S100A9 is found to promote M1 macrophage polarization and impair dorsal root ganglion (DRG) neuronal activity. Mechanistically, Gentisic acid binds to MAPK14, downregulates S100A9 via MAPK14, and then suppresses M1 polarization, enhances neuronal autophagic flux, and improves neuronal viability through the S100A9/Rac1/2 pathway. In vivo experiments demonstrate that Gentisic acid ameliorates disc injury, improves neurological function, and alleviates pain in a rat LDH model, with efficacy comparable to celecoxib. These results suggest that Gentisic acid could alleviate LDH symptoms by modulating macrophage polarization and autophagy through the MAPK14/S100A9/Rac1/2 axis, offering a promising therapeutic strategy for LDH.

Authors:Li Shuoqi, Chen Tiezhu, Shen Xiongjie, Su Wanying, Li Xiaosheng Authors:Yuanhua Xie, Wenyi Wu, Dingyu Wu, Liting Zhao, Dan Wen Authors:You Li, Junwen Jiang, Jiameng Li, Siliang Liu, Chuang Wang, Zhengtao Yu, Ying Xia

Danggui Buxue Decoction (DBD) has shown potential antitumor effects in a variety of cancers. This study aims to delve into the effects and mechanisms of DBD on the metastasis of triple-negative breast cancer (TNBC). The mouse model of TNBC was constructed, and the function of DBD was investigated. The active components and core targets of DBD on TNBC were identified through liquid chromatography-mass spectrometry, network pharmacology, and molecular docking techniques. A set of in vitro experiments was conducted to examine the key components and core targets of DBD that affect the metastasis of TNBC. DBD inhibited the growth and metastasis of TNBC tumors. Formononetin is one of the key active ingredients of DBD, exerts antitumor effects by targeting Snail family transcriptional repressor 2 (SNAI2). The addition of DBD or Formononetin inhibited the malignant activity and reduced the expression of SNAI2. However, this ability of Formononetin was reversed due to the overexpression of the SNAI2 gene. Formononetin inhibits the metastasis of TNBC by downregulating SNAI2. The outcomes offer a basis for the future clinical utilization of DBD and Formononetin in TNBC therapy.

Authors:Kui Li, Ting Zhou, Ruoxia Wu, Jiaqing Xiong Authors:Yuan Liao, Wenxia Yao, Zhaoyu Liu, Qian Peng, Xinke Zhou, Mengyuan Xie, Zesen Mai KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY IF:2.2

The progression of renal fibrosis is difficult to reverse, and Poria cocos, one of the main components of Wenyang Zhenshuai Granules, has been shown to be crucial to the development of the epithelial-mesenchymal transition (EMT). This study aimed to examine the molecular mechanism by which Poricoic Acid A (PAA) inhibited the advancement of EMT in renal tubular epithelial (RTE) cells. The protein levels of sprouty RTK signaling antagonist 2 (SPRY2) extracellular regulated protein kinases (ERK), and p-ERK were measured. The EMT progression of RTE cells was evaluated by a series of experiments. The regulatory relationship of PAA to SPRY2 was determined by cycloheximide, molecular docking and drug affinity target stability and immunoprecipitation. The overexpression of SPRY2 or PAA intervention suppressed the HK-2 and NRK-52E cell's viability, proliferation and migration ability of TGF-β1-induced while raising the levels of E-cadherin and decreasing those of collagen I, collagen III, Fibronectin1, α-SMA, Vimentin, ZEB1, Twist, Snail and Slug. PAA was able to be combined with SPRY2 protein. Besides, we found that PAA intervention increased the stability of SPRY2 through the ubiquitin-proteasome pathway, did not affect ERK levels, and reduced the levels of p-ERK. Finally, we found that inhibiting SPRY2 negated the beneficial effect of PAA on TGF-β1-stimulated RTE cells. PAA alleviated the EMT of RTE cells by modulating the SPRY2/ERK pathway.

IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL IF:1.5 Authors:Chen Jiye, Chen Jiayao, Li Qinxia, Hu Minxia, Zhong Xingxing, Yu Liang, Zhang Xi, Huang Hongyu, Liu Jing, Huang Ziyi, Liu Xinyi, Xiong Wu Authors:Yin Yuqiang, Ma Zhenxin, Yuan Siwen, Xu Kangfeng, Wang Xiaofeng AML12细胞专用培养基由abiowell技术团队精心筛选验证,经过长期测试,本产品可保持AML12细胞最佳的生长状态。本产品中已包含AML12细胞生长所需的各种成分,无需额外添加任何成分,可直接用于AML12细胞的体外培养。

04完整参数表

参数由厂商资料整理,采购前请以最终报价单与技术协议为准。

规格500ml DMEM/F12基础培养基
形态液体
细菌检测阴性
谷氨酰胺2.5mM
D-葡萄糖3151mg/L
HEPES缓冲剂15mM
丙酮酸钠0.5mM
碳酸氢钠含有
酚红含有
存储条件2℃-8℃,避光储存
运输条件常温或者蓝冰
有效期12个月
供应限制仅供科研使用
货号AW-M006

05荣誉与资质

该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。

  • 营业执照未上传
  • 品牌授权未上传
  • 产品检测报告未上传
会员身份
收费会员
经营身份
原厂
成立年份
2016 年
所在地
湖南
收录条目
498 个
平台核验
平台代管
向品牌方索取资质文件

06品牌与供应商

艾碧维 原厂
Abiowell

进入企业主页
498 本目录条目
产地 / 总部湖南省长沙高新区
成立年份2016 年
本目录主营蛋白与抗体 / 生化试剂 / 细胞生物学 / 分子生物学

公司产品涵盖抗体、细胞、培养基、质粒载体等多个领域,致力于为生命科学研究提供可靠的工具与解决方案。自创立以来,艾碧维始终秉持“求实、诚挚、勤勉、克己”的发展理念,坚持以自主研发与持续创新为核心动力。公司拥有百余人的团队,其中硕士及以上学历生物医学专业人才占比超过30%,包括博士4人,构建起一支结构合理、专业扎实的研发与服务队伍。通过设立研发部、生产部、市场与营销部、财务部等多功能部门,公司实现了从产品开发到市场推广的全流程管控。艾碧维不仅敢于质疑现状,积极为生命科学家突破技术壁垒提供支撑,更注重与客户的深度互动与合作,通过持续收集反馈、开展研发协作,提前预见并解决潜在问题。未来,公司将继续秉持“助力科研创新,让实验更简单”的使命,一步一个脚印地打造具有国际领先水平的技术研发与产业化平台,为全球生命科学领域的进步持续赋能。注意: 1.本公司产品仅供科研使用。

售后与服务

品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。

引用此条目 产品目录 · 更新于 2026-10-31
科研在线(TeleVM). DMEM/F12基础培养基(AW-M006)[EB/OL]. 产品目录, 2026-10-31. https://www.suprotek.cn/products/item/aw-m006.html.
TeleVM. (2026, October 31). DMEM/F12基础培养基(AW-M006). 产品目录. https://www.suprotek.cn/products/item/aw-m006.html
@misc{biocsp_item_aw_m006,
  title        = {DMEM/F12基础培养基(AW-M006)},
  author       = {{科研在线}},
  year         = {2026},
  howpublished = {产品目录},
  note         = {更新于 2026-10-31,产品目录},
  url          = {https://www.suprotek.cn/products/item/aw-m006.html}
}

GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。

许可:CC BY-NC 4.0 · 转载注明来源
获取正式报价

DMEM/F12基础培养基

提交后由平台转给品牌方,通常 1 个工作日内联系。不需要注册。